CRISPR Therapeutics
Series BCRISPR Therapeutics raised €59M in a Series B round in Apr 2015. The company is based in Basel, Switzerland. Investors in the round: Abingworth LLP, Bayer Global Investments, Celgene and 5 others. Data as of Nov 2026.
Amount raised
€59M
€59,485,082
Native amount
64,000,000 USD
Stage
Series B
series b
Investors
8
Provenance & confidence
UnverifiedAmount
64,000,000 USD
ECB-at-date → €59M · rate 1.0759 on 2015-03-31
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
8 namedAbingworth LLPBayer Global InvestmentsCelgeneGlaxoSmithKlineNew Enterprise AssociatesSR OneVersant VenturesVertex Ventures
Date
Apr 2015
Round type
series b
Amount (EUR)
€59M